Archiv
Study: Genome editing works against hemophilia B
U.S. researchers said they were able to use a technique called genome editing to reverse hemophilia B in mice that were engineered to have the bleeding disorder. The method involved injecting the mice with enzymes that can repair...[more]
Researchers discover hepatitis C virus mechanism
Irish researchers have found that a protein secreted by the hepatitis C virus, called E2, prevents an enzyme called protein kinase C beta from performing its normal function in boosting the immune system. The researchers now are...[more]
Grifols expects to finalize Talecris purchase soon
Spanish blood-products company Grifols said it expects to finalize its acquisition of Talecris in early June. The company is confident that it soon will receive the Federal Trade Commission's approval for the merger. Reuters...[more]
MSM in Argentina sues over blood-donation ban
Comunidad Homosexual Argentina has filed a lawsuit in the Buenos Aires Administrative Litigation Court that seeks to lift the blood-donation ban among men who have sex with men. The ban is discriminatory and violates federal,...[more]
Experts concerned over possible babesiosis spread in the blood supply
Studies have found that babesiosis, a disease caused by parasites carried by ticks, is slowly spreading in a number states, and experts have expressed concern about the danger that this could pose to the blood supply. Experts say...[more]
Cerus is determined to gain approval for Intercept
After more than one failed attempt to get FDA approval for its Intercept Blood System, Cerus, with new CEO William Greenman, said it is planning to resume its efforts to obtain the agency's nod for the product. "We need to...[more]
Drug Ups Response Rate in Refractory Hepatitis C
The protease inhibitor, telaprevir (Incivek), markedly improved response rates in patients with hard-to-treat hepatitis C virus (HCV) infection, compared with standard therapy, researchers in two different trials reported. full...[more]